Inventor
EDWARDS LEE
GB22 patents
⚠️ This page may combine multiple inventors who share the name “EDWARDS LEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
10 patentsUS9365552B2Jun 14, 2016
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG5 citations82
US8901134B2Dec 2, 2014
Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
NOVARTIS AG7 citations82
US8039472B2Oct 18, 2011
Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
NOVARTIS AG8 citations82
US10117858B2Nov 6, 2018
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG2 citations71
US9050339B2Jun 9, 2015
Pyrazine derivatives as ENaC blockers
NOVARTIS AG2 citations62
US11911371B2Feb 27, 2024
Pyridine and pyrazine derivative for the treatment of chronic bronchitis
NOVARTIS AG0 citations61
USRE46757EMar 20, 2018
Pyridine and pyrazine derivative for the treatment of CF
NOVARTIS AG1 citations61
US9522149B2Dec 20, 2016
Pyrazine derivatives as ENaC blockers
NOVARTIS AG0 citations51
US8372845B2Feb 12, 2013
Pyrazine derivatives as enac blockers
NOVARTIS AG2 citations51
US7732435B2Jun 8, 2010
Chromone derivatives useful as antagonists of VR1 receptors
NOVARTIS AG0 citations39
BHALAY GURDIP
3 patentsUS9139586B2Sep 22, 2015
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP2 citations59
US8697687B2Apr 15, 2014
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP2 citations59
US9643983B2May 9, 2017
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
BHALAY GURDIP0 citations48